These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38897820)

  • 1. Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment.
    Corso G; Fusco N; Guerini-Rocco E; Leonardi MC; Criscitiello C; Zagami P; Nicolò E; Mazzarol G; La Vecchia C; Pesapane F; Zanzottera C; Tarantino P; Petitto S; Bianchi B; Massari G; Boato A; Sibilio A; Polizzi A; Curigliano G; De Scalzi AM; Lauria F; Bonanni B; Marabelli M; Rotili A; Nicosia L; Albini A; Calvello M; Mukhtar RA; Robson ME; Sacchini V; Rennert G; Galimberti V; Veronesi P; Magnoni F
    Semin Oncol; 2024; 51(3-4):106-122. PubMed ID: 38897820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive lobular carcinoma of the breast: the increasing importance of this special subtype.
    McCart Reed AE; Kalinowski L; Simpson PT; Lakhani SR
    Breast Cancer Res; 2021 Jan; 23(1):6. PubMed ID: 33413533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Review of Molecular Mechanisms and Clinical Features of Invasive Lobular Cancer.
    Pramod N; Nigam A; Basree M; Mawalkar R; Mehra S; Shinde N; Tozbikian G; Williams N; Majumder S; Ramaswamy B
    Oncologist; 2021 Jun; 26(6):e943-e953. PubMed ID: 33641217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast.
    Arps DP; Healy P; Zhao L; Kleer CG; Pang JC
    Breast Cancer Res Treat; 2013 Apr; 138(3):719-26. PubMed ID: 23535842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease.
    Thomas M; Kelly ED; Abraham J; Kruse M
    Semin Oncol; 2019 Apr; 46(2):121-132. PubMed ID: 31239068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
    Guiu S; Wolfer A; Jacot W; Fumoleau P; Romieu G; Bonnetain F; Fiche M
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):235-57. PubMed ID: 25129506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer.
    Van Baelen K; Geukens T; Maetens M; Tjan-Heijnen V; Lord CJ; Linn S; Bidard FC; Richard F; Yang WW; Steele RE; Pettitt SJ; Van Ongeval C; De Schepper M; Isnaldi E; Nevelsteen I; Smeets A; Punie K; Voorwerk L; Wildiers H; Floris G; Vincent-Salomon A; Derksen PWB; Neven P; Senkus E; Sawyer E; Kok M; Desmedt C
    Ann Oncol; 2022 Aug; 33(8):769-785. PubMed ID: 35605746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
    Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
    Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast.
    Jacobs C; Clemons M; Addison C; Robertson S; Arnaout A
    Breast J; 2016; 22(1):45-53. PubMed ID: 26782951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
    Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
    Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
    Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.
    Agostinetto E; Nader-Marta G; Paesmans M; Ameye L; Veys I; Buisseret L; Neven P; Taylor D; Fontaine C; Duhoux FP; Canon JL; Denys H; Coussy F; Chakiba C; Ribeiro JM; Piccart M; Desmedt C; Ignatiadis M; Aftimos P
    Future Oncol; 2022 Jul; 18(22):2383-2392. PubMed ID: 35695563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer.
    Mouabbi JA; Hassan A; Lim B; Hortobagyi GN; Tripathy D; Layman RM
    Breast Cancer Res Treat; 2022 Jun; 193(2):253-264. PubMed ID: 35347549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic and genomic features of invasive lobular breast cancer.
    Desmedt C; Zoppoli G; Sotiriou C; Salgado R
    Semin Cancer Biol; 2017 Jun; 44():98-105. PubMed ID: 28400203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.
    Jung SY; Jeong J; Shin SH; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
    BMC Cancer; 2010 Dec; 10():664. PubMed ID: 21126378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.
    Lim ST; Yu JH; Park HK; Moon BI; Ko BK; Suh YJ
    World J Surg Oncol; 2014 Mar; 12():56. PubMed ID: 24621330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.